An EconoTimes perspective

Gavin Metcalf

Cancer Biologist and Lecturer in Biomedical Science, Anglia Ruskin University

Cancer Biologist and Lecturer in Biomedical Science, Anglia Ruskin University Dr Gavin Metcalf is a Cancer Biologist, Sub-Group Research Lead for Cancer Cell Biology, and Lecturer at ARU, with a broad research experience and interests that cover numerous aspects of cancer including development, invasion/migration, diagnosis, drug resistance and identification of novel drug targets. Gavin completed his translational research training at Imperial College London, being awarded a Masters of Research in Oncology and Cancer Biology and a joint multidisciplinary Doctorate in Medicine and Biomedical Engineering. Whilst at Imperial, he developed a comprehensive knowledge of molecular oncology including cancer cell signalling pathways and diagnostics, as well as organic chemistry skills, including the design and development of novel fluorogenic biosensors. Gavin also completed a postdoctoral research role at the Barts Cancer Institute, London. Research explored stem cell evolution and progression to cancer in disease states that predispose to adenocarcinoma, via histopathological means. Gavin has also previously been employed within the medical devices industry, the NHS, The Wellcome Sanger Institute, and the medical regulatory industry.